Vanguard FTSE All-World e... (VEU)
61.01
0.17 (0.28%)
At close: Apr 02, 2025, 3:59 PM
59.67
-2.19%
After-hours: Apr 02, 2025, 07:59 PM EDT
0.28% (1D)
| Bid | 59.08 |
| Market Cap | 28.22B |
| AUM | 57.9B |
| NAV | 61.26 |
| EPS (ttm) | 3.85 |
| PE Ratio (ttm) | 15.86 |
| Shares Out | 462.66M |
| Inception Date | Mar 2, 2007 |
| Ask | 60.09 |
| Volume | 1.64M |
| Open | 60.46 |
| Previous Close | 60.84 |
| Day's Range | 60.42 - 61.06 |
| 52-Week Range | 55.27 - 63.81 |
| Holdings | 3.83K |
| Expense Ratio | 0.04% |
About VEU
The fund employs an indexing investment approach designed to track the performance of the FTSE All-World ex US Index. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Asset Class International/Global Stock
Ticker Symbol VEU
Inception Date Mar 2, 2007
Provider First Trust
Website Fund Home Page
Top Sectors
| Sector | Weight % |
|---|---|
| Financial Services | 21.45% |
| Industrials | 14.33% |
| Technology | 13.43% |
| Consumer Cyclical | 10.48% |
| Healthcare | 10.00% |
Top 10 Holdings 11.00% of assets
| Name | Symbol | Weight |
|---|---|---|
| Taiwan Semiconductor... | 2330 | 2.53% |
| Tencent Holdings Ltd... | 700 | 1.32% |
| Sap Se | SAP | 1.05% |
| Alibaba Group Holdin... | 9988 | 0.97% |
| Novo Nordisk A/s Cla... | NOVO B | 0.97% |
| Asml Holding N.v. | ASML | 0.97% |
| Nestle Sa | NESN | 0.86% |
| Rogers Corporation | ROG | 0.80% |
| Astrazeneca PLC | AZN | 0.78% |
| Novartis Ag | NOVN | 0.75% |
Dividends Dividend Yield 2.96%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Mar 21, 2025 | $0.1907 | Mar 25, 2025 |
| Dec 20, 2024 | $0.9403 | Dec 24, 2024 |
| Sep 20, 2024 | $0.2470 | Sep 24, 2024 |
| Jun 21, 2024 | $0.4589 | Jun 25, 2024 |
| Mar 15, 2024 | $0.2153 | Mar 20, 2024 |
1 month ago · seekingalpha.com
VEU: International Stocks Outperforming To Start 2025, More Upside AheadI maintain a buy rating on VEU due to its compelling valuation, positive momentum, and broad international exposure, especially in large-cap stocks. The recent performance of VEU suggests a potential ...
